Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed With Metastatic Prostate Cancer

NCT02458716 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT02458716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02458716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Cytoreductive Prostatectomy in Men Newly Diagnosed With Metastatic Prostate Cancer
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 1
Overall status
Completed
Start date
March 6, 2015
Completion date
January 14, 2020
Enrollment
26 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate carcinoma, metastatic prostatic adenocarcinoma, prostate carcinoma metastatic to the bone